CA2429059C - Dispositifs medicaux enrobes pour la prevention et le traitement de l'affection vasculaire - Google Patents

Dispositifs medicaux enrobes pour la prevention et le traitement de l'affection vasculaire Download PDF

Info

Publication number
CA2429059C
CA2429059C CA2429059A CA2429059A CA2429059C CA 2429059 C CA2429059 C CA 2429059C CA 2429059 A CA2429059 A CA 2429059A CA 2429059 A CA2429059 A CA 2429059A CA 2429059 C CA2429059 C CA 2429059C
Authority
CA
Canada
Prior art keywords
stent
rapamycin
compounds
drug
restenosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2429059A
Other languages
English (en)
Other versions
CA2429059A1 (fr
Inventor
Robert Falotico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardinal Health 529 LLC
Original Assignee
Cordis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/431,059 external-priority patent/US7419678B2/en
Application filed by Cordis Corp filed Critical Cordis Corp
Publication of CA2429059A1 publication Critical patent/CA2429059A1/fr
Application granted granted Critical
Publication of CA2429059C publication Critical patent/CA2429059C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

Un médicament et un dispositif d'administration du médicament peuvent servir à traiter des maladies vasculaires. Un dispositif d'administration local est enrobé de rapamycine ou d'un autre médicament, agent ou composé approprié et est administré intraluminalement pour traiter et prévenir une hyperplasie néointimale survenant à la suite d'une angiographie coronarienne transluminale percutanée. L'administration locale de médicaments ou d'agents permet d'augmenter l'efficacité et de réduire la toxicité générale.
CA2429059A 2002-05-20 2003-05-20 Dispositifs medicaux enrobes pour la prevention et le traitement de l'affection vasculaire Expired - Lifetime CA2429059C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38198602P 2002-05-20 2002-05-20
US60/381,986 2002-05-20
US10/431,059 2003-05-07
US10/431,059 US7419678B2 (en) 2000-05-12 2003-05-07 Coated medical devices for the prevention and treatment of vascular disease

Publications (2)

Publication Number Publication Date
CA2429059A1 CA2429059A1 (fr) 2003-11-20
CA2429059C true CA2429059C (fr) 2011-10-25

Family

ID=29584344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2429059A Expired - Lifetime CA2429059C (fr) 2002-05-20 2003-05-20 Dispositifs medicaux enrobes pour la prevention et le traitement de l'affection vasculaire

Country Status (1)

Country Link
CA (1) CA2429059C (fr)

Also Published As

Publication number Publication date
CA2429059A1 (fr) 2003-11-20

Similar Documents

Publication Publication Date Title
US7419678B2 (en) Coated medical devices for the prevention and treatment of vascular disease
AU2001261579B2 (en) Delivery systems for treatment of vascular disease
EP1588726A1 (fr) Système de libération de médicament pour la prévention et le traitement des maladies vasculaires
US20020007214A1 (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
US20020005206A1 (en) Antiproliferative drug and delivery device
US20020007213A1 (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
US20020007215A1 (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
EP1600180A2 (fr) Dispositif d'administration d'agents anti-prolifératifs
EP1588727A1 (fr) Système de libération de médicament pour la prévention et le traitement des maladies vasculaires
AU2001263112A1 (en) Delivery systems for the prevention and treatment of vascular disease
AU2001259774A1 (en) Delivery devices for treatment of vascular disease
AU2001261580A1 (en) Delivery devices for treatment of vascular disease
AU2001263113A1 (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
EP1591135A1 (fr) Système de libération de médicament pour la prévention et le traitement des maladies vasculaires
CA2429059C (fr) Dispositifs medicaux enrobes pour la prevention et le traitement de l'affection vasculaire

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20230523